Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2003

View Archived Issues

New drug with potential in the management of preterm uterine activity

Tacrolimus could improve liver function after liver transplantation

Bezafibrate diminishes insulin resistance and improves lipid metabolism in hypertriglyceridemia

LY-333531 reduces diabetic hyperalgesia

KF-24345: an adenosine uptake inhibitor with antiinflammatory properties

Roxithromycin has antiallergic activity

Lilly presents new melanocortin MC4 agonists in a recent patent

BMS scientists prepare novel HIV reverse transcriptase inhibitors

FDA approval for Gamunex

Pharmacia patent covers novel oxazolidinone-based antibacterial agents

Potent and selective CDK4 inhibitors identified by Warner-Lambert researchers

Dainippon licenses AC-3933 to Aventis

Novel HCV NS3 protease inhibitors in early development at Schering-Plough

SCRAS describes dual lipid peroxidation inhibitors/sodium channel modulators and their use

New dosage strengths approved for Avandamet

NICE recommends first-line treatment with Glivec for newly diagnosed CML patients

Schering AG plans phase III Crohn's disease study of Leukine

Syn X Pharma finalizes Alzheimer's agreement with Ortho-Clinical Diagnostics

Phase I study evaluates new breast cancer detection method

Enrollment commences in phase I trial of Dacogen plus Proleukin for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...